Nymox Pharmaceutical Corporation (NYMX) - Financial and Strategic SWOT Analysis Review

1
Nymox Pharmaceutical Corporation (NYMX) -
Financial and Strategic SWOT Analysis Review
Company Profiles and Conferences
2
Summary

• Nymox Pharmaceutical Corporation (NYMX) -
  Financial and Strategic SWOT Analysis Review
  provides you an in-depth strategic SWOT analysis
  of the companys businesses and operations. The
  profile has been compiled by GlobalData to bring
  to you a clear and an unbiased view of the
  companys key strengths and weaknesses and the
  potential opportunities and threats. The profile
  helps you formulate strategies that augment your
  business by enabling you to understand your
  partners, customers and competitors better.
• The profile contains critical company information
  including
• Business description A detailed description of
  the companys operations and business divisions.
• Corporate strategy Analysts summarization of
  the companys business strategy.

Mob 919223375060 / 919223767111
3

• SWOT Analysis A detailed analysis of the
  companys strengths, weakness, opportunities and
  threats.
• Company history Progression of key events
  associated with the company.
• Major products and services A list of major
  products, services and brands of the company.
• Key competitors A list of key competitors to
  the company.
• Key employees A list of the key executives of
  the company.
• Executive biographies A brief summary of the
  executives employment history.
• Key operational heads A list of personnel
  heading key departments/functions.

Mob 919223375060 / 919223767111
4

• Highlights
• Nymox Pharmaceutical Corporation (Nymox) is a
  biopharmaceutical company. It undertakes the
  research and development of therapeutics and
  diagnostics devices to target the unmet needs of
  the aging population. The companys lead drug
  candidate is NX-1207, which is administered by
  urologist and is undergoing phase III clinical
  trials in the US for the treatment of BPH (benign
  prostatic hyperplasia).. The diagnostic products
  of the company include NicAlert and TobacAlert,
  these products have already been commercialised.

Mob 919223375060 / 919223767111
5
Table of Contents

• Section 1 - About the Company
• Nymox Pharmaceutical Corporation - Key Facts
• Nymox Pharmaceutical Corporation - Key Employees
• Section 2 Company Analysis
• Nymox Pharmaceutical Corporation - Business
  Description
• Nymox Pharmaceutical Corporation - SWOT Analysis
• Section 3 Company Financial Ratios
• Financial Ratios - Capital Market Ratios
• Financial Ratios - Annual Ratios

Mob 919223375060 / 919223767111
6
Custom Research

• There are times when you may not find the company
  profile of your choice in our database. If that
  is the case then you must go for customized
  research. Our multifarious capabilities,
  cross-sector expertise and detailed knowledge of
  various markets, put us at a unique position to
  take up Custom Research demands of the
  customers. 
• We provide the specifications of the custom
  research job to a dedicated team comprising of
  researchers, analysts and industry experts, who
  have close experience and understanding of global
  markets, competitive landscapes, various business
  models, market shares, drivers, restraints and
  benchmarks. The Custom Research is highly
  insightful and actionable. 

Mob 919223375060 / 919223767111
7
To know more Nymox Pharmaceutical Corporation
(NYMX) - Financial and Strategic SWOT Analysis
Review

z

• Contact Us Mob 919223375060 /
  919223767111Fax [phone] Email id
  info_at_companyprofilesandconferences.com

www.companyprofilesandconferences.com